Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors
暂无分享,去创建一个
F. Gao | C. Liang | L. Ratner | D. Morgensztern | G. Selvaggi | M. Amin | Haeseong Park | S. Waqar | A. Wang-Gillam | M. Baggstrom | S. Devarakonda | N. Bagegni | Katlyn Kraft | Maura O-Toole